TELA Bio, Inc. Deferred Income Tax Expense (Benefit)
TELA Bio, Inc. (TELA) reported Deferred Income Tax Expense (Benefit) of $144.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-25
- TELA Bio, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $59.00K.
- TELA Bio, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- TELA Bio, Inc. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was $33.00K.
- TELA Bio, Inc. deferred income tax expense (benefit) for the quarter ending 2025-03-31 was $52.00K.
- TELA Bio, Inc. deferred income tax expense (benefit) for fiscal 2025 was $144.00K.
- TELA Bio, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$144.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $59.00K derived: sum of 2 quarters · filed 2026-03-25 | $92.00K derived: sum of 3 quarters · filed 2026-03-25 | $144.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $33.00K derived: sum of 2 quarters · filed 2025-11-14 | $85.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $85.00K 10-Q · filed 2025-08-11 | ||
| 2025-03-31 | $52.00K 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | -$144.00K 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |